April 14, 2023, In light of the changes in the status of COVID-19 under the Infectious Disease Control Law and other factors, JPO has decided to terminate the handling provisionally stipulated for cases affected by COVID-19 and return to the operation of the conventional relief measures.
This conventional remedy requirement applies to proceedings in which the last day of the procedural period (the statutory or designated period (before the extension of the period) is on or after May 9, 2023 (Tuesday).
Japan Patent Office
https://www.jpo.go.jp/e/news/koho/saigai/covid19_procedures.html
December 28, 2021
The JPO has Updated information on remedies based on "reasons of force majeure" and "good cause" when prescribed procedures are affected by COVID-19.
Details are as follows
Japan Patent Office
https://www.jpo.go.jp/e/news/koho/saigai/covid19_legitimate_reasons.html
July 10, 2020
In response to the Japanese government's declaration of a state of emergency, we are adjusting our operations accordingly.
At this point, we are currently moving most of our patent attorneys and staff in our main Osaka office to remote telework.
Our Tokyo office has already been transitioned to telework, whereas our Hiroshima office is doing business as usual.
Overall, we can continue to meet the needs of our clients without interruption.
Each of us can be reached by email though some at home may not be reached by phone.
We would appreciate your understanding and will remain focused on our clients to maintain our standards for prompt, high quality services during this difficult time.
Japan Patent Office
https://www.jpo.go.jp/e/news/koho/saigai/covid19_procedures.html
Location